Michael Petusky

Stock Analyst at Barrington

(1.24)
# 3,517
Out of 4,407 analysts
636
Total ratings
41.7%
Success rate
-0.4%
Average return

Stocks Rated by Michael Petusky

LeMaitre Vascular
Jun 3, 2026
Maintained: Buy
Price Target: $120
Current: $91.96
Upside: +30.49%
Orthofix Medical
May 22, 2026
Maintained: Buy
Price Target: $17$15
Current: $9.32
Upside: +60.94%
Bioventus
May 22, 2026
Maintained: Buy
Price Target: $14
Current: $8.51
Upside: +64.51%
U.S. Physical Therapy
May 13, 2026
Maintained: Buy
Price Target: $103$90
Current: $65.56
Upside: +37.28%
Haemonetics
May 12, 2026
Maintained: Buy
Price Target: $94$89
Current: $78.20
Upside: +13.81%
Lifecore Biomedical
May 7, 2026
Maintained: Buy
Price Target: $6
Current: $5.65
Upside: +6.19%
DENTSPLY SIRONA
May 6, 2026
Maintained: Buy
Price Target: $17
Current: $10.09
Upside: +68.48%
Henry Schein
May 6, 2026
Maintained: Buy
Price Target: $97
Current: $81.22
Upside: +19.43%
Option Care Health
May 1, 2026
Maintained: Buy
Price Target: $42$32
Current: $20.76
Upside: +54.14%
Merit Medical Systems
May 1, 2026
Maintained: Buy
Price Target: $107
Current: $66.53
Upside: +60.83%
Maintained: Buy
Price Target: $17
Current: $14.72
Upside: +15.49%
Downgraded: Hold
Price Target: n/a
Current: $1.42
Upside: -
Maintained: Buy
Price Target: $1$1.5
Current: $0.69
Upside: +117.39%
Downgraded: Hold
Price Target: n/a
Current: $0.015
Upside: n/a
Initiated Coverage: Buy
Price Target: n/a
Current: $57.55
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Upgraded: Buy
Price Target: $30
Current: $26.20
Upside: n/a
Rated: Buy
Price Target: $6.5
Current: $1.07
Upside: n/a